---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "NeuroMind"
developer_entity: "DecisiX BV"
bundle_id: "com.DigitalNeurosurgeon.NeuroMind"
app_store_id: "353386909"
google_play_id: "eu.dign.NeuroMind"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2022-12-08"
report_date: "2026-09-12"
last_verified: "2026-09-12T00:00:00.000Z"
report_version: "2022.12.08"
total_reviews: 267
overall_rating: 4.1
sentiment: "Excited"
sentiment_score: 65
confidence: "medium"
confidence_score: 0.55
top_praise_theme: "Medical professionals value the quick navigation of neurological scores for bedside patient assessment and stratification"
top_complaint_theme: "Mandatory access codes without clear instructions prevent users from launching the application after the latest update"
review_sample_size: 43
total_review_count: 43
analyzed_review_count: 43
data_age_days: 19
momentum_velocity: "zombie"
intelligence_version: 2
tags: ["medical", "free", "excited sentiment", "mobile app", "app review", "app analysis", "neurosurgeons", "neurologists", "requiring"]
canonical_url: "https://marlvel.ai/apps/neuromind"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# NeuroMind Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Rating 4.14 · Sentiment Excited
- **Recent focus**: Mandatory access codes without clear instructions prevent users from launching the application after the latest update (top complaint) · Medical professionals value the quick navigation of neurological scores for bedside patient assessment and stratification (top praise)

> **TL;DR:** NeuroMind is a medical app by DecisiX BV, rated 4.14/5 by 267 users, with Excited user sentiment (65/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** NeuroMind maintains Excited user sentiment (4.14/5 from 267 reviews), with users consistently praising medical professionals value the quick navigation of neurological scores for bedside patient assessment and stratification.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.14/5 (267 reviews) |
| **User Mood** | Excited |
| **Category** | Medical |
| **Developer** | DecisiX BV |
| **Pricing** | Free |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.55/1.0) |
| **Data Age** | 19d |

## Metadata & Market Performance
- **Publisher:** DecisiX BV
- **Category:** Medical
- **Target Audience:** Neurosurgeons and neurologists requiring quick access to clinical decision-making tools.
- **Platforms:** iOS & Android
- **Version Reviewed:** 2022.12.08
- **Report Date:** 2026-09-12
- **Signal Count:** 43 reviews analyzed
- **Confidence:** Medium (0.55/1.0)
- **App Store ID (iOS):** 353386909
- **Bundle ID:** com.DigitalNeurosurgeon.NeuroMind
- **Google Play ID:** eu.dign.NeuroMind
- **Data Window:** Analysis based on signals collected up to 2026-09-12

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** NeuroMind is a clinical decision support tool for neurosurgeons and neurologists, providing rapid access to medical scoring and classification systems on iOS and Android.
**Why users hire it:** It removes the cognitive friction of manual calculation during bedside patient assessment, serving as a reliable ready-reckoner for clinical practice.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Clinical Scoring Systems:** Rapid access to medical scoring and classification frameworks for neurosurgery and neurology.
- **[Differentiator] NeuroMind Academy:** Educational content portal linked within the application interface.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

NeuroMind occupies a niche utility space in the Medical category, holding a 4.33 rating on iOS and 4.14 on Android. The lack of updates since late 2022 suggests the app is currently in maintenance mode rather than active growth.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free access to all clinical scoring and classification tools
- **Analysis:** The app operates as a free, utility-focused tool for medical professionals with no visible subscription or pay-gate.

<!-- section:sentiment -->
## 🟢 User Sentiment (Medium Confidence: 43 of 43 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 4.14/5
- **Platform Split:** iOS 4.3/5 (3 ratings) | Android 4.1/5 (264 ratings)
- **Overall Sentiment:** Excited

### Top Praises
- **Medical professionals value the quick navigation of neurological scores for bedside patient assessment and stratification**
- **The application serves as a reliable reference for neurosurgeons and clinicians managing neurological patients**

### Top Complaints (Impact Areas)

- **Mandatory access codes without clear instructions prevent users from launching the application after the latest update**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Category authority as a clinical reference tool builds a defensible brand position among medical professionals

**Growth Levers:**
- Adding a traumatic brain injury prognosis calculator would directly address the top-requested utility gap


<!-- /section:swot -->
<!-- section:whats-new -->
## What's New

- **Latest (v2022.12.08, 3 years ago):** Integrated a direct link to NeuroMind Academy.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Last major release December 2022.
- Integrated NeuroMind Academy link.

> **Cadence:** 1 total versions · 1 majors in last 6 months · 1373 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

NeuroMind is a market-leading medical app that is completely free.
With a 4.14/5 rating from 267 reviews, it delivers strong user satisfaction.

<!-- speakable-start -->
> **Bottom Line:** NeuroMind retains a core professional user base through its specialized scoring utility, but the current access-code friction and technical instability threaten its clinical reliability. Resolving the onboarding barrier would immediately restore the tool's utility for its target audience.
<!-- speakable-end -->

**Best for:** Neurosurgeons and neurologists requiring quick access to clinical decision-making tools.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] Remove the mandatory access code requirement because it is the primary barrier to app entry → restore user access
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Declining

The medical reference market is shifting toward high-frequency update models that ensure clinical accuracy and OS compatibility. NeuroMind's lack of development since 2022 leaves it exposed to newer, more reliable competitors, and the current onboarding friction will likely continue to compress its active user base.

- 🔴 The 45-month release gap indicates the app is in maintenance mode, which increases the risk of abandonment as OS requirements evolve.
- 🔴 Mandatory access codes without instructions prevent new users from launching the app, which directly accelerates churn and negative sentiment.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.14/5 |
| Total Reviews | 267 |
| Sentiment | Excited (65/100) |
| Confidence | Medium |
| Pricing Model | Free |
| Platforms | iOS & Android |
| Key Features | 2 analyzed |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **NeuroMind** (this app) | 4.14/5 | Excited | DecisiX BV |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** DecisiX BV
- **Website:** [https://www.decisix.nl](https://www.decisix.nl)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/neuromind/id353386909?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=eu.dign.NeuroMind&hl=en&gl=us)
- **Dev Site:** [Official Website](https://www.decisix.nl)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.55/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 43
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 19 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/neuromind)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.